A study in 2014 by Herrmann H et al., on BM samples from CML patients, confirmed the presence of CD34+ CD38-/CD26+ LSCs that are specific to CML. This evidence concerns the gene CD34 and chronic myelogenous leukemia, BCR-ABL1 positive.